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Multi-drug-resistant bacteria are a major cause of hospital-acquired infections and 
antibiotic resistance in these organisms is often plasmid mediated, which has become a 
growing concern. Plasmids conferring resistance to multiple antibiotics are increasingly 
becoming a common source of antibiotic resistance. The behavior of these plasmids 
under and in the absence of selective pressure is not yet fully understood. Therefore, to 
determine the behavior of a multiple-resistance plasmid under selective pressure pCR 
2.1-TOPO, a commercial plasmid, was inserted into an Escherichia coli host and grown 
in a continuous culture under four conditions: broth with 1) kanamycin alone, 2) 
ampicillin alone, 3) with both kanamycin and ampicillin, and 4) without antibiotics. 
Samples were taken every two weeks, frozen, and later cultured on a replica plate series 
to identify mutants whose plasmids no longer conferred resistance to one or both 
antibiotics. The plasmids of these mutants were isolated, sequenced, and compared. The 
sequence data were analyzed to determine how the plasmid-mediated resistance genes 
changed over time. These results show the effects of selection pressure on the plasmid 
itself rather than on the organism by antibiotics and relates to the overall problem of 
antibiotic resistance in medicine and animal science by contributing to the understanding 
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Multi-drug-resistant bacteria are a major cause of hospital-acquired infections and 
antibiotic resistance in these organisms is often plasmid mediated, which has become a 
growing concern1. Plasmids conferring resistance to multiple antibiotics are increasingly 
becoming a common source of antibiotic resistance2. The behavior of these plasmids 
under and in the absence of selective pressure is not yet fully understood3. To better 
understand this behavior this study examined the effects of long-term exposure to 
antibiotics on plasmid-mediated antibiotic resistance genes.  
The plasmid pCR 2.1-TOPO (Figure 1) carries genes conferring resistance to 
kanamycin via aminoglycoside 3´-phosphotransferase and ampicillin via penicillin-
binding protein 1A. The TOP10 (Invitrogen, Carlsbad, CA) strain of Escherichia coli was 
transformed with the pCR 2.1-TOPO plasmid and isolated using blue/white screening. 
From this isolated colony, four continuous cultures were established in Luria-Bertani 
(LB) broth media with kanamycin alone, ampicillin alone, both antibiotics, or without 
antibiotics at concentrations known to inhibit the growth of susceptible TOP10 E. coli. 
Samples of the continuous cultures were taken and frozen every two weeks and the 
minimum inhibitory concentration (MIC) later determined using Etest strips for each 
sample to kanamycin and ampicillin. To identify mutations that caused changes in MIC, 
each saved sample was cultured on a replica plate series and the MICs determined for the 
unique colonies isolated. The plasmids of these cultures were isolated and shipped to 
GeneWiz (South Plainfield, NJ) for nucleotide sequencing. The sequence data were 
analyzed using the Molecular Evolutionary Genomic Analysis (MEGA) tool. Lastly, 
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resistance to antibiotics to which the isolated samples were previously susceptible was 
regained by culturing the samples in sub-inhibitory concentrations of the antibiotics. 
 
Introduction to Plasmid Biology 
 Conjugation is the most common and powerful method of horizontal gene 
transfer, in which plasmids are transferred between individual bacteria4. Plasmids, which 
are small, autonomous, extra-chromosomal pieces of DNA, can be considered the trading 
cards of bacterial cultures. Bacterial chromosomes contain the basic genes necessary for 
the proper growth and replication of the cell. These genes are the tried-and-true tools 
bacterial species have used to survive for millennia and which have undergone little 
change over time.  
In contrast, plasmids are distinctly separate from the chromosome and tend to 
contain genes that confer traits such as resistance to antibiotics and other substances, 
metabolism of complex compounds or the production of such molecules, virulence 
factors, and other miscellaneous properties that are usually only transiently valuable to 
the cell5. Like trading cards, these plasmids can be gained as they become valuable in 
environments in which they are needed or lost when their value no longer merits the cost 
incurred by carrying them6. Due to the numerous functions plasmids may confer upon 
their hosts, especially the ability to confer resistance to antibiotics, and their current use 
in the study of molecular biology, the study of plasmids is an important avenue of 
research. For the purposes of this study, plasmid biology is presented as the history, 
classification, replication control, replication, inheritance, dissemination, and the clinical 
importance of plasmids. The methods of replication control, replication, inheritance, and 
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dissemination of plasmids vary and therefore general patterns for these processes will be 
discussed before discussing the method used by the pCR 2.1-TOPO plasmid used in this 
study.  
 
History of Plasmid Research 
 The term plasmid was coined by Joshua Lederberg in 1952 in the journal 
Physiological Reviews, in which he stated,  
 
“These discussions have left a plethora of terms adrift: pangenes, plastogenes, 
chondriogenes, cytogenes and proviruses, which have lost their original utility 
owing to the accretion of vague or contradictory connotations. At the risk of 
adding to this list, I propose plasmid as a generic term for any extrachromosomal 
hereditary determinant. The plasmid may be genetically simple or complex7.”  
 
Originally, the study of plasmids was limited to microbial geneticists who studied them 
as mechanisms of gene exchange, but upon the discovery of their role in the spread of 
antibiotic resistance, a much wider audience became interested in plasmids.  
Plasmids were discovered during studies conducted in the 1940s and 50s that 
were examining recombination in E. coli. These studies found that sexual differentiation 
was attributable to the presence or absence of a transmissible factor called F (for 
fertility). These cells could be classified as either F+ or F- based on the presence or 
absence of the F factor. Invariably, it was found that the transfer of genetic information 
was unidirectional: F+ cells transferred genetic information to F- cells, which then became 
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F+ themselves7. This pattern of transmission of plasmids through conjugation from cell to 
cell was soon discovered to be responsible for another property of microbes that came as 
a surprise.  
From the very beginning of the use of antibiotics in medicine, laboratories had 
been able to isolate resistant strains that had arisen from mutations in the chromosome, 
generally arising from point mutations8. These strains arose relatively infrequently. In 
striking contrast, soon after the development of single antibiotic resistance in clinical 
settings, the appearance and rapid spread of multiple antibiotic resistance plasmids led to 
the study of plasmids that today has made them indispensable tools in molecular biology. 
  
Plasmid Classification 
 In an attempt to organize the large number of plasmids that were being 
discovered, with all their functional diversity, a classification system based on the 
replication system of the plasmid, a property common to all plasmids, was developed. 
This classification system, known as incompatibility grouping, is based on the inability of 
two plasmids to co-exist stably in the same cell line if they share the same replication 
system as defined by their origins of replication9. Many plasmids produce a repressor that 
inhibits replication of the plasmid at sufficient concentrations or an inducer that is 
responsible for the induction of replication. This concentration varies from plasmid to 
plasmid, but is responsible for the determination of plasmid copy number10. Plasmids that 
share the same repressor system will affect each other’s rate of replication by each 
producing the repressor until the concentration of repressors is high enough to inhibit 
replication. The total number of plasmids will be approximately the same as if a single 
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plasmid were present despite the presence of two distinct plasmids11. Upon fission of the 
cell, the distribution of plasmids of each type to the daughter cells occurs at random. This 
leaves the plasmid composition of each cell to chance, eventually producing daughter 
cells containing a single plasmid. This is only a general pattern; however, as some 
plasmids of the same incompatibility group may not have the same copy number, and, in 
such cases, the plasmid at the higher copy number will out-replicate their competitors and 
in other plasmids, partitioning systems for the distribution of plasmids between daughter 
cells exist. In contrast, plasmid pairs that are not in the same incompatibility group do not 
have repressors that inhibit replication of the opposite plasmid and their relative 
contribution to the extra-chromosomal gene pool and copy number are consistent from 
generation to generation11. This system for the classification of plasmids is not without its 
weaknesses. Some plasmids contain more than one origin of replication that interferes 
with the ability of incompatibility testing. Other plasmids may have mutations that cause 
otherwise-incompatible and evolutionarily related plasmids to be considered 
compatible11. Other methods utilizing molecular probes are able to determine the 
presence of multiple replicons and small mutations within the replicon in order to more 
accurately classify plasmids into incompatibility groups9. 
  
Control of Plasmid Replication  
 The replication of plasmids independent of their host chromosome is one of their 
defining characteristics; however, their actions are not orchestrated entirely without 
regard to the proceedings of their hosts. In order to persist within a population, the 
replication rate of the plasmid cannot be sustained at a rate greater than that of the host 
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cell to prevent the risk of imposing a detrimental cost upon the host. Conversely, the 
replication rate cannot be sustained at less than the rate of host cell division which would 
eventually produce cells that lack the plasmid. The mechanisms by which replication is 
controlled are, therefore, an important aspect of plasmid biology. The models that have 
been proposed to explain the controlled replication of plasmids can be divided into two 
categories: passive and active12.  
 Passive control strategies are those in which the plasmid copy number is limited 
by an external constraint. This may be a host-encoded protein that is essential for the 
initiation of replication13. In light of the incompatibility groups discussed previously, it is 
unlikely that a single host-encoded factor could be responsible for the regulation of the 
replication of plasmids. However, in natural environments with limited nutrient 
availability, passive control of plasmid replication due to the limitations of the cell’s 
resources can influence the plasmid replication rate and copy number12.  
 For active control systems, control of the rate of plasmid replication is determined 
by genes encoded within the plasmid itself. Two model systems for the control of 
replication rates have been proposed: the inhibitor dilution model and the autorepressor 
model, which differ in the encoded replication control gene being either a repressor or 
initiator of replication14. In the inhibitor dilution model, replication inhibitors are 
produced at a concentration proportional to plasmid copy number. The inhibitors function 
by binding to the origin of replication. Some inhibitors, instead of binding to the origin of 
replication, will bind to plasmid encoded initiators to inhibit the synthesis of proteins 
necessary for the initiation of replication. At a low plasmid copy number, inhibitor 
concentration is also low, which leaves the origin or initiator predominately unbound by 
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inhibitors, and replication of the plasmid is able to proceed. At higher copy numbers, 
inhibitor concentration is also higher and results in the inhibitor binding to the origin or 
initiator, thereby preventing further replication of the plasmid until the inhibitor 
concentration decreases when the cell either grows larger or divides14.  
 In the autorepressor model, replication of the plasmid is meditated by an initiator 
protein that binds to the origin of replication and initiates replication. Within the operon 
coding for the initiator is also an autorepressor that is co-transcribed with the initiator. 
The autorepressor regulates the rate of transcription of both proteins by binding to the 
promoter-operator region of the autorepressor/initiator operon, and thereby maintains a 
constant concentration of both proteins. In some cases the autorepressor and initiator are 
a single bi-functional protein15. 
 The plasmid pCR 2.1-TOPO contains the pUC origin of replication which is a 
derivative of the pMB1 origin of replication. The pMB1 origin does not require plasmid-
encoded functions for its replication. It instead relies on replication enzymes produced by 
the host cell16. The pUC origin of replication within the pCR 2.1-TOPO plasmid also 
requires host enzymes for replication; however, the loss of the rop gene, responsible for 
regulation of the plasmid copy number, and a mutation in the rep gene, responsible 
initiation of replication, result in a copy number of 500-700 plasmids per cell17. This 
property is useful for the purposes of this study as the aim is to determine the effects of 
long-term exposure to antibiotics on the resistance genes themselves. Complications 
arising from mutations to other plasmid-encoded proteins are thereby avoided. However, 
this large copy number also makes the detection of mutations within a single plasmid 
extremely hard to isolate unless the plasmid with the mutation becomes the dominant 
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plasmid within the cell, as the phenotype of the bacteria is determined by the sum of the 
actions of the total plasmid population within that bacterial cell. With few plasmids 
carrying the mutation that would make the cell susceptible to an antibiotic, it is not until 
many generations after the mutation arises that it could be observed. 
 
Plasmid Replication  
 The replication of plasmids is controlled, as discussed previously, at the level of 
initiation in a manner specialized for the maintenance of plasmids at an appropriate copy 
number; however, once replication is initiated, it proceeds in a manner very similar to 
that of chromosomal replication. Plasmid replication begins with the binding of a Rep 
protein, specific for the replicon present in the plasmid, to the interon sequence located 
near the origin of replication. Interons are short, repeated DNA sequences that, when 
bound by the Rep protein, separate the adjacent DNA sequence high in adenine and 
thymine12. This allows DNA helicase enzymes to enter the melted portion and further 
unwind the DNA template to reveal sites for the binding of the primer and the initiation 
of replication. The Rep protein and helicase enzymes are referred to as the pre-priming 
complex. Once the primer site is revealed, a primase enzyme synthesizes an RNA primer. 
The RNA primer is then extended with DNA by the enzyme DNA polymerase III in the 
leading and lagging strands10. 
 There are a few special mechanisms for plasmid replication that are markedly 
different from the process described above. Rolling circle replication is a common form 
of replication in high-copy-number plasmids of Staphylococcus, Lactobacillus, 
Mycoplasma, Streptococcus, and Streptomyces. During rolling circle replication, the Rep 
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protein makes a single stranded break at the origin or replication while maintaining its 
attachment to the 5´-terminus of the break. The exposed 3´-terminus serves as a primer 
for the leading-strand DNA to be extended by DNA polymerase. RNA polymerase forms 
an RNA primer on the lagging strand at the palA locus, a point in the plasmid where a 
hairpin loop forms in the displaced strand. The lagging strand is then extended by DNA 
polymerase18. 
 Another mechanism, called theta replication, in which there is no requirement for 
a plasmid-encoded Rep protein, is common in Col plasmids and other related multicopy 
plasmids. The initiation of theta replication begins with the transcription of a preprimer 
RNA approximately 555bp upstream of the origin of replication by RNA polymerase. 
The RNA transcript elongates as RNA polymerase travels towards the origin of 
replication and folds into a configuration which assists in the formation of a stable RNA-
DNA hybrid at the origin of replication. Next, an endonuclease catalyzes the cleavage of 
the RNA strand of the RNA-DNA complex at the origin of replication, leaving behind 
what is essentially a primer, though not one produced by RNA primase. The 3´-terminus 
of the RNA transcript left behind after the cleavage of the RNA from the RNA-DNA 
complex is then extended by DNA polymerase. Downstream of the origin, unwinding 
reveals a primosome assembly site where lagging-strand synthesis is initiated10. 
 The plasmid pCR 2.1-TOPO contains the pUC origin of replication. This origin of 
replication utilizes theta replication. As mentioned previously, the pCR 2.1-TOPO 
plasmid does not encode any of its own replication enzymes, and therefore uses the host 
cells RNA polymerase, endonucleases, DNA polymerase, and other enzymes required for 
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replication. The benefits and drawbacks of this with regard to this study were discussed 
previously. 
 
Control of Plasmid Inheritance 
 For a plasmid to exist stably within a population, it must be inherited by both 
daughter cells reliably during cell division. This requires that the plasmids must replicate 
on average once per generation. Once the plasmid has replicated, the products of 
replication must be distributed between both daughter cells when the cell undergoes 
division. If this is not accomplished, a daughter cell receiving no plasmid DNA at cell 
division would give rise to a clone of plasmid-free descendants. There are different 
strategies used by high- and low-copy-number plasmids to deal with this issue.  
 Upon division of a bacterial cell, only extremely infrequently is there an instance 
in which one of the daughter cells does not receive a copy of the chromosome. This 
implies that there is a mechanism in place to ensure the equal distribution of
 chromosomal DNA. For low-copy-number plasmids, similar mechanisms are 
required to ensure the inheritance of plasmids to daughter cells reliably. Two strategies to 
ensure the stable inheritance of low copy number plasmids have been proposed: 
equipartition and pair-site partitioning, though each assumes an association between the 
plasmid and cell membrane. In equipartition, half of the plasmids are inherited by each 
cell. In pair-site partitioning, a single pair of plasmids is partitioned into each daughter 
cell while the remaining plasmids are distributed randomly. For plasmids with a 
functioning copy number control system this is enough to ensure the continued presence 
of the plasmids within the cell line19. 
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 High-copy-number plasmids tend to segregate to daughter cells by random 
distribution. While this is unsuitable for low-copy-number plasmids, high-copy-number 
plasmids are able to be stably inherited by random distribution alone19. For a single 
plasmid, the probability of being distributed to each daughter cell is 0.5. For a high-copy-
number plasmid, the probability of a single daughter cell receiving all of the plasmids 
present in 0.5n, where n is the copy number of the plasmid. Since each cell divides into 2 
daughter cells, the segregation frequency, or the probability that either one of the 
daughter cells will receive no plasmid, is 2(0.5)n 12. 
 The plasmid pCR 2.1-TOPO has a copy number of between 500 and 700 plasmids 
per cell and is distributed randomly to daughter cells17. At such a high copy number, the 
probability that the plasmid will not be inherited by both daughter cells is, for the 
purposes of this experiment, infinitesimal. That is not to say the presence of the pCR 2.1-
TOPO plasmid is guaranteed once it enters a cell line. The metabolic load imposed on the 
host by the presence of the plasmid, such as the increase in generation time and use of 
cell components for replication, accelerates the rate of plasmid loss in the population. For 
the plasmid pCR 2.1-TOPO, the fitness cost imposed by the production of antibiotic-
resistance products would, in cultures lacking antibiotics, form a situation in which the 
eventual loss of the plasmid would occur as cells lacking the plasmid out-compete their 






Methods of Plasmid Dissemination  
 Plasmids play an indispensable role in the evolution of bacterial species by 
providing a reservoir of genetic information transmissible between species. Plasmids can 
be transferred between cells in three ways: transduction, transformation, and conjugation. 
 Transduction occurs when a bacteriophage infecting a cell assembles its protein 
coat and bacterial chromosomal or plasmid DNA is inserted instead of phage DNA. The 
amount of DNA inserted is determined by the size and shape of the plasmid, with sizes 
similar to the phage genome being inserted most efficiently12. The phage protein behaves 
as if phage DNA were present and is able to bind to bacterial cells and insert the 
chromosomal or plasmid DNA. Once in the cell, plasmids need only regain their previous 
conformation to re-initiate autonomous replication. This method of horizontal gene 
transfer generally occurs in closely related species of bacteria, as the receptors for phage 
entry must be similar, and, therefore, it is likely that transduction is a less important 
means of gene transmission than conjugation, though transduction of plasmid DNA has 
been demonstrated in soil, fresh water, and waste water environments20.  
 Transformation is the genetic alteration of a cell resulting from the uptake, 
integration, and expression of heterologous stretches of exogenous DNA from the 
surroundings through the cell membrane. Transformation is commonly used in molecular 
biology procedures to force cells to express foreign DNA; however, the procedures used 
in this process are not encountered in nature20. Natural transformation does occur and 
proceeds in several stages. The first stage is the acquisition of competence, or the ability 
to be transformed.  This is accomplished in Gram-positive bacteria by accumulating a 
specific low-molecular-weight protein, a competence factor, from the local environment. 
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The next stage in transformation is the binding of DNA to the cell surface. Gram-
negative species do not accumulate competence factors and, instead, undergo a period of 
unbalanced growth at the very end of the exponential phase of growth just before the 
stationary phase, during which the cells express genes for membrane-associated double 
stranded DNA binding proteins. Next, the DNA is transferred into the cell, and, finally, is 
integrated. The integration of plasmid DNA is easier than fragments of chromosomal 
DNA, as plasmids do not need to be integrated into the host chromosome to function12.  
 The third mechanism of horizontal gene transfer, conjugation, is the transfer of 
plasmids between individuals via cell-to-cell contact. This gene exchange can occur 
between an enormous variety of bacterial species. A large number of conjugation systems 
have been identified in both Gram-negative and Gram-positive species. The plasmids that 
encode for their own conjugative factors are restricted by their size and tend to exist at 
low copy numbers to avoid an excessive metabolic cost to the host cell12. The process of 
conjugation begins with the synthesis of an extracellular pilus, essential for the 
maintenance of the intra-cellular environment that protects the plasmid DNA during 
transfer and for cell contact. These pili can be divided into those that are long (1µm) and 
flexible or short (0.1µm) and rigid. The type of pilus influences the rate of conjugation in 
different situations. After the pilus contacts the recipient cell, the pilus retracts, bringing 
the cells into close contact forming the DNA transport pore. Next, a single strand nick is 
introduced at the origin of transfer on the plasmid within the donor cell and the nicked 
strand is transferred to the recipient cell through the DNA transport pore. Once inside the 
recipient cell, the complementary strand is synthesized while the non-donor strand is also 
copied so the donor retains an intact plasmid20. 
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 The plasmid pCR 2.1-TOPO in this study has been transformed into the TOP10 
strain of E. coli, which is a strain of E. coli lacking the fertility plasmid, and, therefore, 
cannot undergo conjugation. For the purposes of understanding how the antibiotic-
resistance genes present are affected by long-term exposure to antibiotics, this property of 
the host E. coli is beneficial. The two factors that should determine the rates of bacteria 
carrying the pCR 2.1-TOPO plasmid are the random inheritance at cell division and the 
relative fitness of cells containing or lacking the plasmid. 
 
Clinical Importance of Plasmids 
 Plasmids provide a large reservoir of highly mobile genes which, due to the 
restricted size of bacterial genomes, is utilized for the adaptation of bacterial species in 
changing environments12. These environments need not be natural, as demonstrated by 
one of the best documented examples for plasmid-driven evolution: the spread of 
antibiotic resistance.  
Resistance to antibiotics was observed almost immediately after the introduction, 
mass production, and widespread use of most antibiotics. Typically, resistance was traced 
to spontaneous mutations on the bacterial chromosome. This was not seen as a cause for 
worry, as the probability of an individual bacterium obtaining mutations that would 
confer resistance to multiple antibiotics simultaneously was thought to be very low, and 
would only occur in environments where antibiotic exposure was common. To the 
surprise of many, transfer of antibiotic resistance between species was soon demonstrated 
with the transfer of multiple-antibiotic resistance from Shigella flexneri to E. coli and 
Klebsiella pneumonia in a mouse intestine in the absence of antibiotics8. The newly 
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discovered transfer of multiple antibiotic resistance between species stimulated interest in 
the subject and it was discovered that this resistance was independent of the chromosome. 
Soon, the transfer of resistance was compared to the activity of F plasmids and the 
plasmid-borne nature of antibiotic resistance was discovered.  
That is not to say that all antibiotic resistance is plasmid mediated. Methicillin 
resistant Staphylococcus aureus (MRSA), for example, gains resistance to methicillin via 
a mutation in the gene encoding the penicillin binding protein. Further accumulation of 
resistance determinants from transposons led to the resistance of MRSA to many other 
antibiotics, leading to its current notoriety in clinical settings21. Despite this, antibiotic 
resistance plasmids are an important source of antibiotic resistance. In studying antibiotic 
resistance plasmids, it is important to understand how plasmids gain resistance genes, 
how these plasmids spread among bacterial species and interact with human populations, 
and how these genes persist within populations that are no longer exposed to antibiotics. 
 Unlike the point mutations that resulted in methicillin resistance in 
Staphylococcus aureus, the acquisition and loss of resistance genes on plasmids occurs as 
whole genes and gene blocks are reshuffled within plasmids and the host chromosome, 
generally due to the actions of transposons. Transposons come in two classes, known as 
Class I and Class II transposons. Class I transposons are also referred to as “copy-and-
paste” transposons as they copy themselves and are inserted into a new position. Class II 
transposons are also known as “cut-and-paste” transposons. These transposons are able to 
excise themselves from the sequence of DNA and insert in a new place12. Regardless of 
which type of transposon is present, when a transposon is inserted on both sides of an 
antibiotic resistance gene, it forms a composite transposon that is able to be copied or 
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excised as a whole, mobilizing the resistance gene. Once this composite transposon is 
inserted into a plasmid, it becomes an antibiotic-resistance plasmid. If a resistance gene is 
already present on the plasmid, a multiple resistance plasmid is formed. These 
transposons can also move from plasmid to plasmid, making the development of multiple 
antibiotic resistance plasmids even more rapid, especially in the presence of high levels 
of antibiotics selecting for the presence of the resistance genes22. 
 Antibiotic-resistance genes are transferred to populations of pathogens that 
interact with human populations in a variety of ways. The significant selective pressure 
exerted on antibiotic resistance genes in healthcare settings, the agricultural use of 
antibiotics, and ecological exposure to antibiotics all contribute to the transmission of 
antibiotic-resistance genes from the non-pathogenic environmental organisms and 
contribute to the selection pressure for antibiotic-resistance genes to persist in microbial 
populations.  
Antibiotic-resistance genes are commonly found in hospital settings and, once 
introduced, these genes are known to spread rapidly23. There are several properties of the 
environment of hospitals that influence this rapid spread of resistance genes. Many of the 
bacteria that cause problems in hospitals are those that are present even in healthy 
individuals, however, when these bacteria acquire resistance genes and antibiotic 
treatments kill off other normal flora, they can cause life-threatening infections as they 
proliferate to fill the now-empty niches of their competitors24. Meanwhile, the high rate 
of antibiotic use for treatment of infections, as well as for prophylaxis during surgical 
procedures, generates a high level of selection for resistant phenotypes. Once the resistant 
phenotypes are present, hospital staff may act as a vector for the transmission of 
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pathogens between patients. With patients constantly entering and leaving the hospital 
environment and hospital staff potentially transmitting resistant bacteria between patients, 
resistance genes are able to enter into the community and, due to the chronic nature of 
many illnesses, other hospitals if the patient is re-admitted while still carrying resistant 
bacteria23. 
 It is estimated that over 70% of the antibiotics used in the United States are not 
used to treat infections, but as a growth enhancer for agricultural purposes25. These 
practices have been banned elsewhere due to the propensity of this practice to generate 
antibiotic resistance. Use of antibiotics for growth enhancement is at sub-therapeutic 
levels, that is, levels that are insufficient to kill the susceptible microorganisms. This 
allows the susceptible populations to gain resistance in a step-wise fashion utilizing small 
phenotypic changes over time, whereas therapeutic doses are high enough that a sudden, 
large phenotypic change is required26. This becomes a problem when resistance gained 
by agricultural organisms is transferred to human populations27. The use of avoparcin in 
the European Union is a prime example of this process at work. Avoparcin, an analogue 
of vancomycin, was used extensively in feed on poultry and pig farms. In the mid-1990s 
a study of the rates of vancomycin-resistant Enterococci (VRE) in Denmark showed that 
pigs and poultry on farms where avoparcin was used as a growth promoter were three 
times as likely to carry VRE. Even after the use of avoparcin was banned in 1997, the 
rates of VRE remained above the levels observed in areas that were isolated from the 
avoparcin use. Countries that were in contact with countries that used avoparcin also saw 
a rise in VRE isolates without actually using avoparcin themselves28.  
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 Many antibiotics are isolated from soil bacteria that naturally produce them. The 
restrictions on nutrient availability and space for soil microbes has led to fierce 
competition between species and these bacteria have evolved a large armament of 
chemical weapons we call antibiotics. In addition to the production of antibiotics, 
mechanisms of resistance have evolved in soil bacterial to the antibiotics produced by 
themselves and other species. Although not all are useful for the treatment of infectious 
diseases, antibiotics isolated from soil bacteria are an important source of antibiotics29. 
Streptomycin, the first aminoglycoside antibiotic, was isolated from the soil bacterium 
Streptomyces griseus and current searches for novel antibiotics are being conducted in 
several labs using soil bacteria30. The resistance genes found in soil bacteria are also an 
important source of the spread of resistance genes into human pathogens. A survey of the 
antibiotic resistome, the collection of all the antibiotic resistance genes and their 
precursors, of 480 species of soil bacteria showed that there were no antibiotics that were 
effective against all species and, on average, each species was resistant to 8 of the 18 
antibiotics tested31. These resistance genes in soil bacteria, through the mechanisms 
discussed previously, are capable of being transmitted to human pathogen populations. 
This becomes a problem when clinical antibiotics are introduced into the environment. 
Many antibiotics are cleared from the human body unchanged and can eventually make 
their way to environmental bacterial populations25. As with agricultural use at sub-
therapeutic levels, this environmental exposure to low levels of antibiotic can help to 
generate antibiotic resistance that can then be transferred to human populations. 
 The clinical, agricultural, and environmental exposure of antibiotics all form a 
feedback system to generate and spread antibiotic resistance. However, even when the 
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use of antibiotics is stopped, resistance can be retained in pathogen populations. 
Understanding the factors that contribute to the retention and loss of antibiotic resistance 
over time will continue to be paramount to the prevention of the spread and development 
of antibiotic resistance. The roles that clinical, agricultural, and soil systems play in the 
persistence and spread of resistance genes show that antibiotic-resistance genes tend to 
persist in populations even when exposure to the antibiotics themselves has been lowered 
to sub-inhibitory levels or removed completely. The reasons for this persistence are not 
fully understood but can be attributed to the physical linkage of resistance genes and 
evolutionary processes compensating for the burden or carrying resistance genes. 
 Under the pressure of selection by the use of antibiotics, resistance genes can 
form non-random associations that aid in the retention of antibiotic-resistance genes in 
the absence of the antibiotic. These genes can cluster on plasmids and conjugative 
transposons. If several antibiotic-resistance genes are clustered on a plasmid or 
conjugative transposon, the presence of only one of the antibiotics exerts enough 
selective pressure that the entire resistance cassette is maintained32. How these clusters of 
resistance genes react over time in exposure to antibiotic conditions is not fully 
understood. 
 Keeping in mind that antibiotic resistance genes impose a fitness cost upon the 
host bacteria when expressed, it is easy to assume that, in the total absence of antibiotics, 
the population would eventually revert to sensitivity to antibiotics as susceptible 
individuals are no longer burdened by the imposed fitness cost of producing antibiotics. 
Unfortunately, this is not always the case. Compensatory mutations in genes other than 
the resistance genes can ameliorate the cost of antibiotic resistance while retaining the 
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resistance genes; therefore, when compensatory mutations are coupled with resistance 
genes, a high level of fitness can be achieved relative to susceptible competitors. 
However, when the compensatory mutations are detrimental to fitness when lacking 
resistance genes, the loss of resistance in these individuals causes a reduction of fitness 
greater than those individuals in which the compensatory mutation has not occurred and 
the resistance genes are still present32. This can establish a one-way street wherein the 
evolution of antibiotic resistance is not difficult, and, in the presence of antibiotics, is 
necessary, but the loss of resistance imposes a greater fitness cost than retention of the 
resistance genes and, therefore, resistance is maintained despite the loss of selection 
pressure33. 
 The activity of antibiotic-resistance genes in the absence of selective pressure is 
not yet fully understood and, to this end, I have chosen to subject a multiple-resistance 
plasmid to several antibiotic conditions to determine how these genes change over time. 
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MATERIALS & METHODS 
 
Obtaining the Ancestral E. coli  
The original Top10 E. coli (Invitrogen, Carlsbad, CA) for this project was 
transformed by Dr. Yasuhiro Kobayashi and obtained on a Petri dish containing Luria-
Bertani (LB) media, Xgal, and the transformed E. coli sample, known as a blue/white 
screen. From this blue/white screen, a single blue transformed colony was selected and 
transferred to a new LB plate and streaked for isolation. A colony selected from the 
isolation plate was then placed into 5mL of LB broth with 50µg/mL of kanamycin and 
ampicillin and grown overnight at 37˚C while on a gyrorotatry shaker set at 
approximately 100 rev/min. All other overnight incubations were conducted in this 
manner unless otherwise stated. A 750µl sample of this overnight culture was mixed with 
250µl of 60% glycerol and stored at -80ºC to serve as an ancestral record. 
 
Establishment of Continuous Cultures 
From the overnight culture, four continuous culture environments were 
established. Fifty µL of the overnight culture from the ancestral E. coli were added to 8 
culture tubes containing 5mL of fresh LB media. The cultures differed in the antibiotic 
content and were designated Con A, Con B, KanA, KanB, AmpA, AmpB, KA A, and KA 
B. The replicate cultures were used as a backup in case a culture failed to grow or was 
unusable. The positive control group, Con A and Con B, contained no antibiotics. The 
kanamycin group, Kan A and Kan B, were cultured in 50µg/mL kanamycin. The 
ampicillin group, Amp A and Amp B, were cultured in 50µg/mL of ampicillin. The 
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negative control group, KA A and KA B, were cultured in 50µg/mL of both kanamycin 
and ampicillin.  
 
Continuous Culture  
At approximately the same time each day, the cultured E. coli were transferred to 
fresh media to simulate a continuous exposure to the antibiotics. This was accomplished 
by transferring 50µl of the previous day’s culture to 5mL of fresh media containing the 
appropriate antibiotics. The distribution of antibiotics in the cultures was maintained 
throughout the entire experiment and, therefore, was the same as that used in establishing 
the continuous cultures. After the continuous culturing procedure was completed, the 
previous day’s cultures were discarded and the new cultures were incubated at 37˚C and 
agitated via gyrorotary shaker at approximately 100 rpm. 
 
Freezing Samples for Later Use  
At two-week intervals, samples of the continuous culture were frozen for later use 
in MIC testing, replica plating, and gene sequencing. Sample preservation was carried out 
by mixing 750µl of overnight culture media containing the E. coli to 250µl of 60% 
glycerol. Samples were then labeled with the culture designation and date of storage and 
stored at -80˚C until needed for later use. 
 
Minimum Inhibitory Concentration Determination 
Etest strips (BioMerieux, Durham, NC) were used to determine the MIC of 
antibiotics on the frozen samples. Frozen samples were thawed and 50µl were added to 
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5mL of LB media and incubated at 37°C overnight. No antibiotics were added during this 
culturing. Approximately 24 hours later the samples were removed from the incubator. 
Using a 0.5 McFarland standard as a template for the required inoculum turbidity, 
varying amounts of the E. coli sample were added to a sterile 0.85% saline solution in a 
spectrophotometer cuvette until the absorbance matched the absorbance of the 0.5 
McFarland standard. After the correct absorbance was reached, the cuvette was labeled 
and placed in a sealed container until all samples were standardized. At this inoculum 
density, a confluent lawn of growth was obtained. The amount of culture required to 
accomplish the suggested inoculum turbidity varied with each culture, likely due to 
variations in culture density from overnight incubation. 
 The inoculation of Petri dishes to produce a bacterial lawn was accomplished by 
dipping a sterile swab in the inoculum suspension, removing excess fluid by pressing the 
swab against the inside wall of the cuvette, and carefully streaking the plate in 4 
directions, each approximately 45 degrees apart. The plates were then allowed to dry. 
Drying occurred primarily while the remainder of the Petri plates to be used were 
inoculated or, in the case of the final plates, while the previous plates had Etest strips 
applied to them. 
 On the face of the Etest strip is a label indicating the antibiotic present and a 
logarithmic scale used to determine the MIC once growth is visible on the Petri dish. The 
back of the Etest strips contain varying amounts of antibiotic corresponding to the scale 
on the face of the strip. To apply the Etest strip, it was grasped at the top with flame-
sterilized forceps, its bottom touched to the Petri dish, and released to fall into proper 
position. By placing the Etest strips away from the center of the plate, two Etest strips can 
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be placed in an anti-parallel orientation to ensure the formed ellipses do not overlap to 
determine the MIC of two antibiotics on the same plate. After inoculation and application 
of the Etest strips, the Petri plates were stacked in an inverted position in sets of five and 
incubated at 37ºC overnight. 
 Approximately 24 hours later, once bacterial growth was visible to the naked eye, 
the MICs were determined by observing where the inhibition ellipse intersects the Etest 
gradient strip. When growth occurred along the entire strip then no inhibition had 
occurred and the MIC was reported as equal to or greater then the highest value on the 
Etest strip. 
 
Sample Dilution and Replica Plate Series 
Replica plating is a technique in which one or more secondary Petri plates 
containing a selective marker, in this case the presence or absence of a combination of 
antibiotics, are inoculated with colonies from a master plate in such as way that they 
retain their spatial orientation.  
 Initially a master plate was created. The master plate was produced in a nearly 
identical manner to the Petri plates used in Etest MIC testing with the exception of 
further dilution once the 0.5 McFarland standard inoculum densities were achieved. 
Frozen samples were thawed and 50µl were added to 5mL of LB media and cultured 
overnight. No antibiotics were added during this culturing. Approximately 24 hours later, 
the samples were removed from the incubator. Using the 0.5 McFarland standard as a 
template for the required inoculum turbidity, varying amounts of the E. coli sample were 
added to a sterile 0.85% saline solution in a spectrophotometer cuvette until the 
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absorbance matched the absorbance of the 0.5 McFarland standard. This inoculum was 
then further diluted to 1/1000th the original density with sterile 0.85% saline. The cuvette 
was labeled and placed in a sealed container until all samples were prepared. At this 
inoculum density, the plates formed between 200-300 colonies per plate after 24 hours.  
 The replica plate series consisted of 5 plates. Plate 1 was the master plate. Plate 2 
contained Xgal and kanamycin. Plate 3 contained Xgal and ampicillin. Plate 4 contained 
Xgal, kanamycin, and ampicillin. The final plate, plate 5, was a control plate that 
contained Xgal, but no antibiotics. Transfer of colonies was accomplished by pressing the 
master plate upon a sterile velveteen-covered disk. The velveteen cloth retained an 
imprint of the colonies of the master plate. Next, plates 2-5 were sequentially and 
carefully inoculated by the velveteen cloth by pressing them onto the cloth while 
maintaining the orientation of the plate to match the master plate. The inoculated replica 
plate series was then placed into the 37ºC incubator overnight. 
 
Replica Plate Mutant Identification 
After plates 2-5 were cultured overnight, photographs were taken of each plate on 
a colony counting apparatus. The apparatus consists of a light, a magnifying glass, and a 
grid pattern to aid in counting colonies. The light used is indirect so that it does not cause 
a glare on the Petri dish. The photographs taken of each colony were then cropped, 
centered, and enlarged to highlight the center of the Petri plates. In a manner similar to a 
blink comparator used to identify celestial objects as they move against the background 
of stars, the pictures of plates 2 and 3 were rapidly oscillated. This rapid oscillation 
allowed for the easy identification of mutant colonies that were capable of growth in the 
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presence of one but not both antibiotics. Plate 4 was used as a confirmation of the ability 
to grow only in the presence of a single antibiotic, while plate 5 was a positive control. 
 
Replica Plate Mutant MIC Determination 
Etest strips were used to determine the MIC of the identified replica plate 
mutants. Colonies isolated in the replica plate mutant identification step were sampled via 
a sterile inoculation loop and then cultured in 5mL LB media without antibiotics and 
placed in the 37ºC incubator. Approximately 24 hours later, the samples were removed 
from the incubator. From this point forward, the procedure for the determination of the 
MIC of the replica plate mutants is identical to that used to determine the MIC of the 
frozen samples. 
 
Plasmid Isolation  
The preparation of plasmid DNA by alkaline lysis with SDS34 used in this 
instance is an alternative to the Wizard Plus SV Miniprep that provided a high plasmid 
yield. This plasmid isolation procedure is initiated by inoculating 3mL of TB broth, 
containing the appropriate antibiotics at 50µg/mL, with 50µl of saved culture. For 
cultures saved during the continuous culture, the antibiotics used were the same as those 
used for the continuous culture. For the isolated mutants from the replica plate series, the 
antibiotic used was the same as the antibiotic the plate on which the mutant colony was 
found. The inoculated TB broth was then cultured overnight at 37°C with shaking at 100 
rpm. 
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 From the overnight culture, 1.5mL were transferred to a sterile 1.5mL 
microcentrifuge tube and centrifuged at 12000 rpm for 35 seconds. The supernatant was 
then decanted so that only the cell pellet remained. The pellet was stored for 10 minutes 
at -70°C. The pellet was thawed for 5 minutes at room temperature. The pellet was then 
re-suspended in 150µl of Solution 1 with vigorous vortexing.  Three-hundred µl of 
Solution 2 were added and mixed by inversion until the cell suspension had cleared, 
which took approximately 5 minutes. Two-hundred-fifty µl of Solution 3 were added and 
mixed by inversion until no trace of yellow liquid remained. The microcentrifuge tube 
was incubated at -20°C for 15 minutes. This chilled microcentrifuge tube was centrifuged 
for 12 minutes at 13000 rpm.  
 The supernatant from this centrifugation was transferred to a new 1.5µl 
microcentrifuge tube and 750µl of cold (20°C) isopropanol added. The solution was 
mixed by inversion followed by incubation at -20°C for 10 minutes. The plasmid DNA 
was isolated by centrifuging at 12000 rpm for 5 minutes. The supernatant was discarded, 
and the pellet washed with 300µl of 70% EtOH. After washing, the EtOH was discarded 
and any remaining EtOH was removed by vacuum centrifugation. The plasmid DNA was 
re-suspended in 150µl of sterile deionized water and stored at -20°C34.  
 
Plasmid Sequencing 
 The sequencing for this project was conducted by GeneWiz (South Plainfield, NJ) 
using ABI 3730xl DNA Analyzers for capillary electrophoresis and fluorescent dye 
terminator detection. Florescent dye-terminator sequencing utilizes labeling of the chain 
terminator dideoxynucletide triphosphates, ddNTPs, with fluorescent tags, which permit 
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sequencing in a single reaction, rather than the four separate reactions used in labeled-
primer reaction methods. Each of the four ddNTPs is labeled with a florescent dye that 
emits light at a different wavelength. As the sample DNA is separated by size during 
capillary electrophoresis, the fluorescently labeled ddNTPs pass through a laser that 
causes the fluorescent tags to fluoresce. The wavelength of the resulting fluorescence is 
detected by a fluorescence detector and recorded. Initially during the separation of 
fragments of DNA and detection of fluorescence, the wavelength peaks tends to be very 
close together and determining the correct order of bases is not possible but can be done 
manually. For this experiment, the sequence obtained from this florescent dye-terminator 
sequencing is then used in primer walking to obtain the sequence of the whole pCR 2.1-
TOPO plasmid. Primer walking is often used for sequencing DNA fragments between 1.3 
and 7 kilobases as the fragments are too long to be sequenced in a single read using the 
chain-termination method. This method divides the sequence into several short 
sequences, each used to design a primer for the next portion of the sequence which were 
then used to form a consensus sequence that represents the total DNA fragment.  
 
Bioinformatics Software Analysis of Sequence Data 
 The bulk of the previously discussed work was aimed towards the eventual 
identification of mutants susceptible to a single antibiotic, isolation of the plasmid 
responsible for this phenotype, and the acquisition of the nucleotide sequence of this 
plasmid. From these obtained sequences, analysis of the plasmid using bioinformatics 
software was possible. Using the Alignment Explorer tool within the Molecular 
Evolutionary Genomic Analysis (MEGA) program, the sequences of the manufacturers 
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pCR 2.1-TOPO plasmid, the ancestral pCR 2.1-TOPO, and the (Kan) Kan A 12-2-11 
were aligned. This alignment was performed using the Multiple Sequence Comparison by 
Log-Expectation (MUSCLE) method with a gap penalty of -20 and a gap extension 
penalty of -5. The obtained sequences were also mapped using the PlasmaDNA program. 
 
Induction of Resistance in Previously Susceptible E. coli 
The E. coli isolated during the replica plate procedure, from here forward referred 
to as KanR and AmpR, were determined to be susceptible to the antibiotics to which they 
were not exposed during the continuous culture procedure. These E. coli were used to 
inoculate LB broth cultures containing the antibiotic they were deemed susceptible to 
during the MIC determination of replica plate mutants. The KanR E. coli was used to 
inoculate 4 broth cultures containing ampicillin at 2µg/mL, 10µg/mL, 25µg/mL, and 
50µg/mL. The AmpR E. coli was used to inoculate 4 broth cultures containing 
kanamycin at 2µg/mL, 10µg/mL, 25µg/mL, and 50µg/mL. These cultures were then 
incubated overnight. The culture with the highest concentration of antibiotics in which 
growth was observed was used to inoculate 4 new cultures with the same antibiotics at 
the same concentrations. This process was repeated until resistance growth was observed 
in all 4 concentrations of antibiotics for both cultures. 
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RESULTS & DISCUSSION 
 
Minimum Inhibitory Concentration Determination 
 MICs were determined for the samples frozen throughout the experiment using 
Etest strips. The results for the MIC determination for kanamycin and ampicillin are 
represented in Tables 1 and 2. These MICs were determined during the week of 8 July 
2012. 
 Between the 2nd and 4th weeks of the continuous culture in the positive control 
group, the activity of the plasmid to confer resistance to kanamycin and ampicillin 
drastically changed. By the 6th week, all resistance to ampicillin was lost in the positive 
control group and did not vary significantly throughout the rest of the experiment. 
Kanamycin resistance remained at a level below the concentration used during the 
continuous culture, ranging between 24 and 64µg/mL, but did not drop to the baseline for 
Top10 E. coli lacking the pCR 2.1-TOPO plasmid, whose MIC for both kanamycin and 
ampicillin was determined to be 2µg/mL. The reason for the elevated level of resistance 
above the baseline for Top10 E. coli has not yet been elucidated; however the determined 
MIC could have been affected by the amount of E. coli used to inoculate the plates used 
in the MIC determination procedure or the period of time for which the plates were 
incubated. 
For all treatments other than the control treatment, the MIC of kanamycin and 
ampicillin remained at >256µg/mL throughout the duration of the experiment.  This is 
likely due to the rarity of mutations that would confer lowered resistance to these 
antibiotics and the difficulty in detecting these mutants among their resistant cohorts.  
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The results of this procedure demonstrate that the pCR 2.1-TOPO multiple-
resistance plasmid, when exposed to a single antibiotic, retains resistance to both 
antibiotics present in the vast majority of the E. coli carrying the plasmid. However, like 
other plasmids, when no antibiotics are present for a sufficient period, the plasmid is lost, 
as it no longer confers an advantage to the host. 
 
Replica Plate Mutant Identification and MIC Determination 
 The plates produced in the replica series from the dilution of frozen samples were 
evaluated for the presence of colonies that were no longer resistant to both antibiotics. 
Fifteen bacterial colonies were isolated that, upon examination using the methods 
outlined above, appeared to grow in the presence of a single antibiotic. These 15 samples 
were added to LB media lacking antibiotics and grown overnight and then frozen for later 
MIC testing. 
 The 15 samples isolated during the identification of mutants that were able to 
grow in only the presence of a single antibiotic were cultured in order to determine the 
MICs to kanamycin and ampicillin using Etest strips. The results of the MIC 
determination of mutants identified using the replica plate series are listed in Table 3. 
Although 15 colonies were originally identified as mutants, only 2 of the colonies, when 
re-cultured and tested for MIC to kanamycin and ampicillin, showed susceptibility to a 
single antibiotic as indicated by the replica plating procedure. These samples are listed as 
KanR and AmpR in Table 3. This procedure demonstrated that, within a large population 
of resistant E. coli carrying the pCR 2.1-TOPO plasmid, there will be individuals who 
eventually lose resistance to an antibiotic to which they are no longer exposed.  
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Bioinformatics Software Analysis of Sequence Data 
The sequences obtained via the primer walking process from GeneWiz were 
aligned with the manufacturer’s stated sequence for the pCR 2.1-TOPO plasmid as well 
as to each other. GeneWiz was able to determine the sequence of the Ancestral 11/4/11 
plasmid as well as the sample (Kan) Kan A 12/4/11, designated as KanR. The Alignment 
Explorer tool within the MEGA program was used to align the sequences. The sequences 
obtained from GeneWiz showed a 100% identity with each other; however, when 
compared to the sequence provided by the manufacturer there were gaps in the multiple 
cloning site. Upon further examination, it became clear that this gap was caused by the 
usage of the EcoR1 restriction enzyme being used with this plasmid. The portion of the 
alignment showing these gaps is located in Figure 2. This is unlikely to be the cause for 
the phenotypic change in the isolated E. coli, as the multiple cloning site is used for 
inserting genes of interest into the pCR 2.1-TOPO plasmid and the antibiotic resistance 
genes were both over 1300 bases upstream. This procedure demonstrated that, despite the 
presence of the plasmid and the appropriate resistance gene, colonies may be susceptible 
to an antibiotic which they have not been exposed.  
 
Induction of Resistance in Previously Susceptible E. coli 
The KanR and AmpR E. coli isolated on the replica plate were used to inoculate 
LB broth cultures containing the antibiotic to which they were previously deemed 
susceptible during the MIC determination of replica plate mutants. The KanR and AmpR 
E. coli were used to inoculate 4 broth cultures containing ampicillin or kanamycin at 
2µg/mL, 10µg/mL, 25µg/mL, and 50µg/mL and the results of this procedure are listed in 
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the Day 1 row of Table 4. The culture with the highest concentration of antibiotics in 
which growth was observed, from the 2µg/mL culture of the KanR E. coli and the 
25µg/mL culture of the AmpR E. coli, were used to inoculate 4 new cultures with the 
same antibiotics at the same concentrations. After overnight incubation, the Day 2 
cultures were capable of growth in all four antibiotic concentrations. This procedure 
demonstrated that susceptible E. coli containing the appropriate resistance gene can 
quickly regain resistance upon exposure to the appropriate antibiotic. 
 
Discrepancies between Hypothesized and Actual Results 
Initially, I had hypothesized that, after 6 months of exposure to a single antibiotic, 
the vast majority of the E. coli present in the culture would have become susceptible to 
the antibiotic to which it had not been exposed through accumulated mutations in the 
resistance gene that was not under selective pressure to be maintained. Through the MIC 
determination of the saved cultures, it is obvious that this did not occur, as all samples in 
which any antibiotics were present retained resistance to both antibiotics. Further 
contradicting this hypothesis, the isolation of mutants that were resistant to a single 
antibiotic, while susceptible to the antibiotic to which they were not exposed showed that 
these mutants were rare within the populations and when the sequences of the plasmids of 
the isolated E. coli were compared to the sequence of the plasmid used to start the 
continuous culture, the resistance genes had not accumulated any mutations. The reasons 
for this behavior are not clear; however, I believe it is possibly due to linkage of the 
resistance genes, compensatory mutations, or the very high copy number of the pCR 2.1-




 This study aimed to examine the effects of long-term exposure to antibiotics on 
plasmid-mediated antibiotic-resistance genes. This was achieved by continuously 
culturing E. coli containing a multiple-resistance plasmid in different antibiotic 
combinations. The MIC of these cultures was determined at regular intervals and upon 
finding no change in the MIC of cultures regardless of the antibiotic to which they were 
exposed, as long as they were exposed to an antibiotic, a replica plating procedure was 
used to isolate any mutants that were resistant to a single antibiotic. The E. coli isolated 
during this procedure, KanR and AmpR, as well as the plasmid from the E. coli used to 
start the continuous culture, had their plasmids isolated. The isolated plasmids were 
shipped to GeneWiz so that the nucleic acid sequences could be determined using primer 
walking. The obtained sequences were compared showing that the kanamycin and 
ampicillin resistance genes were still present in both of the isolated samples and were 
identical to the genes present before the continuous culture procedure. These samples 
were then cultured in the presence of the antibiotic to which they were deemed 
susceptible in order to induce resistance to the antibiotic. 
 In summary, this experiment has shown that multiple-resistance plasmids tend to 
retain resistance to any antibiotics to which the plasmid confers resistance as long as one 
of the antibiotics in question is present. In a relatively small number of individuals, the 
expression of the resistance gene is reduced and may ultimately be stopped when the 
corresponding antibiotic is not present for long periods of time; however, upon re-
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exposure to the antibiotic, expression of the gene and resistance to the antibiotic are 
quickly regained. 
 To improve upon this project, several changes could be made. First, using a 
plasmid with a lower copy number would aid in identifying colonies in which with 
mutations have arisen or expression of the resistance gene has been reduced. Second, 
using sub-inhibitory concentrations of antibiotic as one of the treatments during the 
continuous culture would be useful in determining if the plasmid would be retained and 
in its original form when antibiotics are present in sub-inhibitory concentrations. Third, 
using a plasmid that confers resistance to more than 2 antibiotics would help in 
determining the exact relationship between the genes present and how the maintenance of 
one gene affects the others. Fourth, using minimally nutritious media in order to increase 
the relative cost of carrying the plasmid would aid in making the plasmid a burden on the 
host so that the plasmid and its resistance genes would be more likely to mutate and 
become non-functional as a mechanism of ameliorating the associated fitness cost.  
Finally, using a plasmid whose resistance genes are farther apart would help in 
determining the role the spatial arrangement of the resistance genes on the retention of 
resistance genes when the antibiotic is no longer present. 
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Figure 2. MEGA alignment results of the manufacturer’s stated sequence of the pCR 2.1-
TOPO plasmid with the reported sequence from GeneWiz for the KanR  and Ancestral 
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Table 1. Minimum inhibitory concentration of kanamycin for each treatment over the 
course of six months in µg/mL. Asterisks (*) signify that colonies were present in the 
formed ellipse. For colonies in which no ellipse was formed, resistance was reported as 
>256µg/mL. 
 
  MIC tested against Kanamycin 





B Kan A Kan B Amp A Amp B KA A KA B 
11/4/2011 >256 >256 >256 >256 >256 >256 >256 >256 
11/18/2011 >256* >256* >256 >256 >256 >256 >256 >256 
12/2/2011 24* 48* >256 >256 >256 >256 >256 >256 
12/16/2011 32 64* >256 >256 >256 >256 >256 >256 
12/30/2011 32 48 >256 >256 >256 >256 >256 >256 
1/13/2012 24 48 >256 >256 >256 >256 >256 >256 
1/31/2012 64* 64 >256 >256 >256 >256 >256 >256 
2/14/2012 32 48* >256 >256 >256 >256 >256 >256 
2/28/2012 48 48 >256 >256 >256 >256 >256 >256 
3/13/2012 64 96 >256 >256 >256 >256 >256 >256 
3/27/2012 48 32 >256 >256 >256 >256 >256 >256 
4/10/2012 32 32 >256 >256 >256 >256 >256 >256 
4/23/2012 64 64 >256 >256 >256 >256 >256 >256 
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Table 2. Minimum inhibitory concentration of ampicillin for each treatment over the 
course of six months in µg/mL. Asterisks (*) signify that colonies were present in the 
formed ellipse. For colonies in which no ellipse was formed, resistance was reported as 
>256µg/mL. 
 
  MIC tested against Ampicillin 





B Kan A Kan B Amp A Amp B KA A KA B 
11/4/2011 >256 >256 >256 >256 >256 >256 >256 >256 
11/18/2011 >256* >256* >256 >256 >256 >256 >256 >256 
12/2/2011 2* 4* >256 >256 >256 >256 >256 >256 
12/16/2011 3* 4* >256 >256 >256 >256 >256 >256 
12/30/2011 2 3 >256 >256 >256 >256 >256 >256 
1/13/2012 0.5 1 >256 >256 >256 >256 >256 >256 
1/31/2012 1.5* 1.0* >256 >256 >256 >256 >256 >256 
2/14/2012 2 2* >256 >256 >256 >256 >256 >256 
2/28/2012 4 2 >256 >256 >256 >256 >256 >256 
3/13/2012 4 3 >256 >256 >256 >256 >256 >256 
3/27/2012 4 2 >256 >256 >256 >256 >256 >256 
4/10/2012 2 3 >256 >256 >256 >256 >256 >256 
4/23/2012 3 3 >256 >256 >256 >256 >256 >256 
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 Table 3. Minimum inhibitory concentrations of kanamycin and ampicillin for samples 
isolated from the replica plate series. For colonies in which no ellipse was formed, 
resistance was reported as >256µg/mL. 
          
  Replica Plate Mutant MIC Results   
  
E. coli Kanamycin Resistance (µg/ml) 
Ampicillin Resistance 
(µg/ml)   
  KanR >256 2   
  AmpR 2 >256   

















Table 4. Induction of antibiotic resistance in previously susceptible E. coli after 
overnight exposure to antibiotics showing growth as + or – for a given culture. KanR E. 
coli is the (Kan) KanA 12/2/11 sample obtained in the replica plate procedure. AmpR E. 
coli is the (Amp) AmpB 3/31/12 sample obtained in the replica plate procedure.  
 
Induction of Antibiotic Resistance 
  
  
Antibiotic Concentration in Broth 
Day E. Coli 10µg/mL 25µg/mL 50µg/mL 100µg/mL 
1 
KanR E. coli + - - - 
AmpR E. coli + + - - 
2 
KanR E. coli + + + + 






























Appendices. Sequences of pCR 2.1-TOPO plasmid provided by the manufacturer, from 
the colony used to start the continuous culture, and those isolated in replica plate series.   
 



































































































































































Appendix 3. pCR 2.1-TOPO Sequence from (Kan) Kan A 12-2-11:  
AGCGCCCAATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGATTCATTAATG
CAGCTGGCACGACAGGTTTCCCGACTGGAAAGCGGGCAGTGAGCGCAACGC
AATTAATGTGAGTTAGCTCACTCATTAGGCACCCCAGGCTTTACACTTTATGC
TTCCGGCTCGTATGTTGTGTGGAATTGTGAGCGGATAACAATTTCACACAGGA
AACAGCTATGACCATGATTACGCCAAGCTTGGTACCGAGCTCGGATCCACTA
GTAACGGCCGCCAGTGTGCTGGAATTCTGCAGATATCCATCACACTGGCGGC
CGCTCGAGCATGCATCTAGAGGGCCCAATTCGCCCTATAGTGAGTCGTATTAC
AATTCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCGTTAC
CCAACTTAATCGCCTTGCAGCACATCCCCCTTTCGCCAGCTGGCGTAATAGCG
AAGAGGCCCGCACCGATCGCCCTTCCCAACAGTTGCGCAGCCTGAATGGCGA
ATGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGC
GCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTC
TTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGG
GGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAA
ACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTT
TTCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAA
ACTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGAT
TTTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTA
ACGCGAATTTTAACAAAATTCAGGGCGCAAGGGCTGCTAAAGGAAGCGGAA
CACGTAGAAAGCCAGTCCGCAGAAACGGTGCTGACCCCGGATGAATGTCAGC
TACTGGGCTATCTGGACAAGGGAAAACGCAAGCGCAAAGAGAAAGCAGGTA
GCTTGCAGTGGGCTTACATGGCGATAGCTAGACTGGGCGGTTTTATGGACAG
 57 
CAAGCGAACCGGAATTGCCAGCTGGGGCGCCCTCTGGTAAGGTTGGGAAGCC
CTGCAAAGTAAACTGGATGGCTTTCTTGCCGCCAAGGATCTGATGGCGCAGG
GGATCAAGATCTGATCAAGAGACAGGATGAGGATCGTTTCGCATGATTGAAC
AAGATGGATTGCACGCAGGTTCTCCGGCCGCTTGGGTGGAGAGGCTATTCGG
CTATGACTGGGCACAACAGACAATCGGCTGCTCTGATGCCGCCGTGTTCCGG
CTGTCAGCGCAGGGGCGCCCGGTTCTTTTTGTCAAGACCGACCTGTCCGGTGC
CCTGAATGAACTGCAGGACGAGGCAGCGCGGCTATCGTGGCTGGCCACGACG
GGCGTTCCTTGCGCAGCTGTGCTCGACGTTGTCACTGAAGCGGGAAGGGACT
GGCTGCTATTGGGCGAAGTGCCGGGGCAGGATCTCCTGTCATCCCACCTTGCT
CCTGCCGAGAAAGTATCCATCATGGCTGATGCAATGCGGCGGCTGCATACGC
TTGATCCGGCTACCTGCCCATTCGACCACCAAGCGAAACATCGCATCGAGCG
AGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCAGGATGATCTGGACGAA
GAGCATCAGGGGCTCGCGCCAGCCGAACTGTTCGCCAGGCTCAAGGCGCGCA
TGCCCGACGGCGAGGATCTCGTCGTGACCCATGGCGATGCCTGCTTGCCGAA
TATCATGGTGGAAAATGGCCGCTTTTCTGGATTCATCGACTGTGGCCGGCTGG
GTGTGGCGGACCGCTATCAGGACATAGCGTTGGCTACCCGTGATATTGCTGA
AGAGCTTGGCGGCGAATGGGCTGACCGCTTCCTCGTGCTTTACGGTATCGCCG
CTCCCGATTCGCAGCGCATCGCCTTCTATCGCCTTCTTGACGAGTTCTTCTGA
ATTGAAAAAGGAAGAGTATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCC
TTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAA
GTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGG
ATCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCA
ATGATGAGCACTTTTAAAGTTCTGCTATGTGGCGCGGTATTATCCCGTATTGA
 58 
CGCCGGGCAAGAGCAACTCGGTCGCCGCATACACTATTCTCAGAATGACTTG
GTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATGGCATGACAGTAA
GAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCGGCCAACTT
ACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAAC
ATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAG
CCATACCAAACGACGAGCGTGACACCACGATGCCTGTAGCAATGGCAACAAC
GTTGCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAAT
TAATAGACTGGATGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGC
CCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGTGAGCGTGGGT
CTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGT
AGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACA
GATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAACTGTCAGACCAA
GTTTACTCATATATACTTTAGATTGATTTAAAACTTCATTTTTAATTTAAAAGG
ATCTAGGTGAAGATCCTTTTTGATAATCTCATGACCAAAATCCCTTAACGTGA
GTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTT
GAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCG
CTACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTCTTTTTCCGAA
GGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTTCTTCTAGTGTAG
CCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGC
TCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTA
CCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTG
AACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGA
ACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGG
 59 
AGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGC
ACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGT
TTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGG
AGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTG
CTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAA
CCGTATTACCGCCTTTGAGTGAGCTGATACCGCTCGCCGCAGCCGAACGACC
GAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAG 
